Pharmasyntez is one of the Russia's corporations active in developing pharmaceutical products and small molecules.
By Russia's invasion of Ukraine and global response to this war crime by heavy sanctions that paralyzed Russia's money and banking system, Primary reports shows that this company is facing big problems from finding professions to the financing R&D Projects
One of the strategic challenge for this Russian company is to access molecular resources and technologies for the research in the laboratories and factories. The thing that under heaviest sanctions of free world economies, made activity of this corporation very hard.
No comments:
Post a Comment